Difficulty: Medium
Average Score: 77%
Practice
The house officer considers prescribing nadolol for a 53-year-old patient. Which of the following preexisting conditions (co-morbidities) would most likely contraindicate safe use of this drug?
Correct answer
B
Rationale
In this scenario, the correct answer is option B) Asthma. Nadolol is a non-selective beta-blocker, which can lead to bronchoconstriction in patients with asthma due to its effect on beta-2 receptors in the lungs. This can exacerbate asthma symptoms and potentially lead to a life-threatening asthma attack.
Option A) Angina pectoris, chronic-stable (effort-induced) is not a contraindication for nadolol as beta-blockers are commonly used to manage angina by reducing myocardial oxygen demand.
Option C) Essential hypertension is not a contraindication for nadolol as beta-blockers are commonly used as first-line agents for hypertension management.
Option D) Heart failure, mild would not necessarily contraindicate the use of nadolol, as beta-blockers are actually recommended in the management of chronic heart failure with reduced ejection fraction to improve outcomes.
Educationally, understanding the contraindications and appropriate use of medications is crucial for healthcare professionals to make safe and effective treatment decisions for their patients. This case highlights the importance of considering a patient's individual comorbidities when selecting pharmacological treatments to avoid potential adverse effects and ensure optimal patient outcomes.
Option A) Angina pectoris, chronic-stable (effort-induced) is not a contraindication for nadolol as beta-blockers are commonly used to manage angina by reducing myocardial oxygen demand.
Option C) Essential hypertension is not a contraindication for nadolol as beta-blockers are commonly used as first-line agents for hypertension management.
Option D) Heart failure, mild would not necessarily contraindicate the use of nadolol, as beta-blockers are actually recommended in the management of chronic heart failure with reduced ejection fraction to improve outcomes.
Educationally, understanding the contraindications and appropriate use of medications is crucial for healthcare professionals to make safe and effective treatment decisions for their patients. This case highlights the importance of considering a patient's individual comorbidities when selecting pharmacological treatments to avoid potential adverse effects and ensure optimal patient outcomes.